Elgi Equipments Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 29, 2025, 9:35 pm

Quick Insight

Elgi Equipments Ltd, with a current share price of 483 and a market capitalization of 15,316 Cr., is displaying a high P/E ratio of 42.2, indicating investor expectations for future growth. The company's robust ROE of 20.1% and ROCE of 21.9% reflect efficient capital utilization, while a healthy OPM of 14% underlines operational efficiency. With a net profit of 350 Cr. and substantial reserves of 1,834 Cr., Elgi Equipments seems well-positioned for sustained growth. However, the relatively high P/BV ratio of 11.83x warrants caution, suggesting the stock may be trading at a premium. Investors should closely monitor the company's debt levels, with borrowings at ₹577 Cr. and an ICR of 18.44x, to assess financial risk and ensure sustainable growth in the long term.

Competitors of Elgi Equipments Ltd

All Competitor Stocks of Elgi Equipments Ltd

Quarterly Result

Last Updated: August 20, 2025, 11:15 am

Below is a detailed analysis of the quarterly data for Elgi Equipments Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 867.00 Cr.. The value appears to be declining and may need further review. It has decreased from 993.00 Cr. (Mar 2025) to 867.00 Cr., marking a decrease of 126.00 Cr..
• For Expenses, as of Jun 2025, the value is 746.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 843.00 Cr. (Mar 2025) to 746.00 Cr., marking a decrease of 97.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 121.00 Cr.. The value appears to be declining and may need further review. It has decreased from 150.00 Cr. (Mar 2025) to 121.00 Cr., marking a decrease of 29.00 Cr..
• For OPM %, as of Jun 2025, the value is 14.00%. The value appears to be declining and may need further review. It has decreased from 15.00% (Mar 2025) to 14.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from 18.00 Cr. (Mar 2025) to 23.00 Cr., marking an increase of 5.00 Cr..
• For Interest, as of Jun 2025, the value is 7.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 8.00 Cr. (Mar 2025) to 7.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 19.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 20.00 Cr. (Mar 2025) to 19.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 118.00 Cr.. The value appears to be declining and may need further review. It has decreased from 140.00 Cr. (Mar 2025) to 118.00 Cr., marking a decrease of 22.00 Cr..
• For Tax %, as of Jun 2025, the value is 27.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 27.00%.
• For Net Profit, as of Jun 2025, the value is 86.00 Cr.. The value appears to be declining and may need further review. It has decreased from 102.00 Cr. (Mar 2025) to 86.00 Cr., marking a decrease of 16.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.70. The value appears to be declining and may need further review. It has decreased from 3.22 (Mar 2025) to 2.70, marking a decrease of 0.52.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 3:54 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 3:18 pm

Below is a detailed analysis of the balance sheet data for Elgi Equipments Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 32.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 32.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,834.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,580.00 Cr. (Mar 2024) to 1,834.00 Cr., marking an increase of 254.00 Cr..
• For Borrowings, as of Mar 2025, the value is 577.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 638.00 Cr. (Mar 2024) to 577.00 Cr., marking a decrease of 61.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 594.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 558.00 Cr. (Mar 2024) to 594.00 Cr., marking an increase of 36.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 3,037.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,807.00 Cr. (Mar 2024) to 3,037.00 Cr., marking an increase of 230.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 592.00 Cr.. The value appears strong and on an upward trend. It has increased from 587.00 Cr. (Mar 2024) to 592.00 Cr., marking an increase of 5.00 Cr..
• For CWIP, as of Mar 2025, the value is 53.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2024) to 53.00 Cr., marking an increase of 43.00 Cr..
• For Investments, as of Mar 2025, the value is 81.00 Cr.. The value appears strong and on an upward trend. It has increased from 41.00 Cr. (Mar 2024) to 81.00 Cr., marking an increase of 40.00 Cr..
• For Other Assets, as of Mar 2025, the value is 2,312.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,170.00 Cr. (Mar 2024) to 2,312.00 Cr., marking an increase of 142.00 Cr..
• For Total Assets, as of Mar 2025, the value is 3,037.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,807.00 Cr. (Mar 2024) to 3,037.00 Cr., marking an increase of 230.00 Cr..

Notably, the Reserves (1,834.00 Cr.) exceed the Borrowings (577.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Elgi Equipments Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 9.86. This value is within the healthy range. It has decreased from 11.72 (Mar 23) to 9.86, marking a decrease of 1.86.
• For Diluted EPS (Rs.), as of Mar 24, the value is 9.86. This value is within the healthy range. It has decreased from 11.71 (Mar 23) to 9.86, marking a decrease of 1.85.
• For Cash EPS (Rs.), as of Mar 24, the value is 12.10. This value is within the healthy range. It has decreased from 14.07 (Mar 23) to 12.10, marking a decrease of 1.97.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 50.84. It has increased from 43.27 (Mar 23) to 50.84, marking an increase of 7.57.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 50.84. It has increased from 43.27 (Mar 23) to 50.84, marking an increase of 7.57.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 101.54. It has increased from 95.95 (Mar 23) to 101.54, marking an increase of 5.59.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 17.07. This value is within the healthy range. It has increased from 15.78 (Mar 23) to 17.07, marking an increase of 1.29.
• For PBIT / Share (Rs.), as of Mar 24, the value is 14.65. This value is within the healthy range. It has increased from 13.32 (Mar 23) to 14.65, marking an increase of 1.33.
• For PBT / Share (Rs.), as of Mar 24, the value is 13.73. This value is within the healthy range. It has decreased from 16.03 (Mar 23) to 13.73, marking a decrease of 2.30.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 9.68. This value is within the healthy range. It has decreased from 11.62 (Mar 23) to 9.68, marking a decrease of 1.94.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 9.84. This value is within the healthy range. It has decreased from 11.70 (Mar 23) to 9.84, marking a decrease of 1.86.
• For PBDIT Margin (%), as of Mar 24, the value is 16.81. This value is within the healthy range. It has increased from 16.44 (Mar 23) to 16.81, marking an increase of 0.37.
• For PBIT Margin (%), as of Mar 24, the value is 14.43. This value is within the healthy range. It has increased from 13.88 (Mar 23) to 14.43, marking an increase of 0.55.
• For PBT Margin (%), as of Mar 24, the value is 13.51. This value is within the healthy range. It has decreased from 16.70 (Mar 23) to 13.51, marking a decrease of 3.19.
• For Net Profit Margin (%), as of Mar 24, the value is 9.53. This value is within the healthy range. It has decreased from 12.11 (Mar 23) to 9.53, marking a decrease of 2.58.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 9.69. This value is within the healthy range. It has decreased from 12.19 (Mar 23) to 9.69, marking a decrease of 2.50.
• For Return on Networth / Equity (%), as of Mar 24, the value is 19.35. This value is within the healthy range. It has decreased from 27.04 (Mar 23) to 19.35, marking a decrease of 7.69.
• For Return on Capital Employeed (%), as of Mar 24, the value is 27.04. This value is within the healthy range. It has decreased from 28.52 (Mar 23) to 27.04, marking a decrease of 1.48.
• For Return On Assets (%), as of Mar 24, the value is 11.05. This value is within the healthy range. It has decreased from 14.82 (Mar 23) to 11.05, marking a decrease of 3.77.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.01.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.34. This value is within the healthy range. It has decreased from 0.37 (Mar 23) to 0.34, marking a decrease of 0.03.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.21. It has increased from 0.99 (Mar 23) to 1.21, marking an increase of 0.22.
• For Current Ratio (X), as of Mar 24, the value is 1.92. This value is within the healthy range. It has increased from 1.79 (Mar 23) to 1.92, marking an increase of 0.13.
• For Quick Ratio (X), as of Mar 24, the value is 1.36. This value is within the healthy range. It has increased from 1.20 (Mar 23) to 1.36, marking an increase of 0.16.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.97. This value is below the healthy minimum of 4. It has decreased from 2.52 (Mar 23) to 1.97, marking a decrease of 0.55.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 20.28. This value is within the healthy range. It has increased from 9.80 (Mar 23) to 20.28, marking an increase of 10.48.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 16.28. This value is below the healthy minimum of 20. It has increased from 8.10 (Mar 23) to 16.28, marking an increase of 8.18.
• For Earning Retention Ratio (%), as of Mar 24, the value is 79.72. This value exceeds the healthy maximum of 70. It has decreased from 90.20 (Mar 23) to 79.72, marking a decrease of 10.48.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 83.72. This value exceeds the healthy maximum of 70. It has decreased from 91.90 (Mar 23) to 83.72, marking a decrease of 8.18.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 18.44. This value is within the healthy range. It has decreased from 25.29 (Mar 23) to 18.44, marking a decrease of 6.85.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 11.45. This value is within the healthy range. It has decreased from 14.30 (Mar 23) to 11.45, marking a decrease of 2.85.
• For Enterprise Value (Cr.), as of Mar 24, the value is 18,846.52. It has increased from 13,869.85 (Mar 23) to 18,846.52, marking an increase of 4,976.67.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 5.86. This value exceeds the healthy maximum of 3. It has increased from 4.56 (Mar 23) to 5.86, marking an increase of 1.30.
• For EV / EBITDA (X), as of Mar 24, the value is 34.84. This value exceeds the healthy maximum of 15. It has increased from 27.74 (Mar 23) to 34.84, marking an increase of 7.10.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 5.92. This value exceeds the healthy maximum of 3. It has increased from 4.58 (Mar 23) to 5.92, marking an increase of 1.34.
• For Retention Ratios (%), as of Mar 24, the value is 79.71. This value exceeds the healthy maximum of 70. It has decreased from 90.19 (Mar 23) to 79.71, marking a decrease of 10.48.
• For Price / BV (X), as of Mar 24, the value is 11.83. This value exceeds the healthy maximum of 3. It has increased from 10.16 (Mar 23) to 11.83, marking an increase of 1.67.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 5.92. This value exceeds the healthy maximum of 3. It has increased from 4.58 (Mar 23) to 5.92, marking an increase of 1.34.
• For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 23) to 0.01, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness